Recruiting Feasibility of a Multi-omics Platform for Hematological Malignancies NCT07445438 Conditions Acute Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +19 more Locations University of Parma — Parma, PR, Italy View Trial Details
Recruiting Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021) NCT07445984 Conditions Acute Leukemia, Bone Marrow Diseases, Chronic Leukemia, +8 more Locations University of Parma — Parma, PR, Italy View Trial Details
Recruiting INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP) NCT07403630 Conditions Acute Leukemia, Adenoma, Adnexal Diseases, +73 more Locations AO Riuniti Villa Sofia-Cervello di Palermo — Palermo, Italy University of Perugia — Perugia, Italy View Trial Details
Completed Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H NCT00048412 Conditions Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more Locations Texas Children's Hospital — Houston, Texas, United States The Methodist Hospital — Houston, Texas, United States View Trial Details
Completed Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006) NCT00542971 Conditions AML, Acute Myeloid Leukemia, Hematologic Diseases, +7 more Locations The University of Texas M.D. Anderson Cancer Center — Houston, Texas, United States View Trial Details
